BACKGROUND: A number of reasons lead patients to choose to undergo weight loss procedures. Previous studies have demonstrated that patients have unrealistic weight loss goals. However, there is a general paucity of information on a patient's expectations in regards to comorbidity improvement and resolution. The purpose of this study is to examine the impact a patient's comorbid conditions have on the motivation to proceed with bariatric surgery. Furthermore, we examined the patient's expectations regarding postoperative weight loss and comorbidity improvement. METHODS: Forty-five subjects completed a modified Goals and Relative Weights Questionnaire assessment 1 week prior to their anticipated bariatric surgery. The first portion addressed a patient's personal weight loss goals and factors that influence their procedure selection. The second part assessed the expectations and evaluations of a variety of specifically determined weight loss outcomes. RESULTS: A total of 45 patients completed the survey (laparoscopic adjustable gastric band (LAGB) 23/45; Roux-en-Y gastric bypass (RNYGB) 22/45). The mean goal percentage of excess weight loss was 85.0% (21-130%). This translated to 80.2% (21-127%) in the LAGB group and 90.5% (37-130%) in the RNYGB group. Of 13 possible reasons, "a desire for change in medical comorbidities" was deemed as most important in choosing a goal weight. Comorbidities with the highest dissatisfaction level included urinary incontinence and hypertension. All patients expected some degree of comorbidity improvement at 1 year postsurgery, with 26% (6/23) expecting a resolution of their diabetes, 36% (10/28) expecting a resolution of hypertension, and 40% (10/25) expecting a resolution of obstructive sleep apnea. CONCLUSION: A dissatisfaction with obesity-related comorbidities, most notably hypertension and urinary incontinence, was a motivating factor in choosing to undergo bariatric surgery. Patients expected improvement in their comorbid illnesses; however, they still possessed unrealistic weight loss expectations for their intended weight loss procedure.
BACKGROUND: A number of reasons lead patients to choose to undergo weight loss procedures. Previous studies have demonstrated that patients have unrealistic weight loss goals. However, there is a general paucity of information on a patient's expectations in regards to comorbidity improvement and resolution. The purpose of this study is to examine the impact a patient's comorbid conditions have on the motivation to proceed with bariatric surgery. Furthermore, we examined the patient's expectations regarding postoperative weight loss and comorbidity improvement. METHODS: Forty-five subjects completed a modified Goals and Relative Weights Questionnaire assessment 1 week prior to their anticipated bariatric surgery. The first portion addressed a patient's personal weight loss goals and factors that influence their procedure selection. The second part assessed the expectations and evaluations of a variety of specifically determined weight loss outcomes. RESULTS: A total of 45 patients completed the survey (laparoscopic adjustable gastric band (LAGB) 23/45; Roux-en-Y gastric bypass (RNYGB) 22/45). The mean goal percentage of excess weight loss was 85.0% (21-130%). This translated to 80.2% (21-127%) in the LAGB group and 90.5% (37-130%) in the RNYGB group. Of 13 possible reasons, "a desire for change in medical comorbidities" was deemed as most important in choosing a goal weight. Comorbidities with the highest dissatisfaction level included urinary incontinence and hypertension. All patients expected some degree of comorbidity improvement at 1 year postsurgery, with 26% (6/23) expecting a resolution of their diabetes, 36% (10/28) expecting a resolution of hypertension, and 40% (10/25) expecting a resolution of obstructive sleep apnea. CONCLUSION: A dissatisfaction with obesity-related comorbidities, most notably hypertension and urinary incontinence, was a motivating factor in choosing to undergo bariatric surgery. Patients expected improvement in their comorbid illnesses; however, they still possessed unrealistic weight loss expectations for their intended weight loss procedure.
Authors: Thomas A Wadden; Meghan L Butryn; David B Sarwer; Anthony N Fabricatore; Canice E Crerand; Patti E Lipschutz; Lucy Faulconbridge; Steven Raper; Noel N Williams Journal: Surg Obes Relat Dis Date: 2006 Mar-Apr Impact factor: 4.734
Authors: Marney A White; Robin M Masheb; Carolyn Burke-Martindale; Bruce Rothschild; Carlos M Grilo Journal: Obesity (Silver Spring) Date: 2007-11 Impact factor: 5.002
Authors: Daniel J Munoz; Mona Lal; Eunice Y Chen; Mayce Mansour; Sarah Fischer; Megan Roehrig; Lisa Sanchez-Johnsen; Maureen Dymek-Valenitine; John Alverdy; Daniel le Grange Journal: Obes Surg Date: 2007-11 Impact factor: 4.129
Authors: Youfa Wang; May A Beydoun; Lan Liang; Benjamin Caballero; Shiriki K Kumanyika Journal: Obesity (Silver Spring) Date: 2008-07-24 Impact factor: 5.002
Authors: Leslee L Subak; Wendy C King; Steven H Belle; Jia-Yuh Chen; Anita P Courcoulas; Faith E Ebel; David R Flum; Saurabh Khandelwal; John R Pender; Sheila K Pierson; Walter J Pories; Kristine J Steffen; Gladys W Strain; Bruce M Wolfe; Alison J Huang Journal: JAMA Intern Med Date: 2015-08 Impact factor: 21.873
Authors: Stephanie C W Aelfers; Wendy Schijns; Nadine Ploeger; Ignace M C Janssen; Frits J Berends; Edo O Aarts Journal: Obes Surg Date: 2017-07 Impact factor: 4.129